ABOUT

David E. Brown
Managing Partner

David Edward Brown has spent 15 years in the aesthetic marketplace with numerous companies and has launched a variety of aesthetic products. Mr. Brown has worked for Collagen Aesthetics which was acquired by Mcghan Medical and later sold to Inamed. In 2005 Inamed was purchased by Allergan. Mr. Brown also spent time at Dermik Aesthetics and Artes Medical before forming his own distribution company. He has been a part of a number of product launches including silicone breast implants for primary augmentation, BOTOX, Scultptra, ArteFill and wide array of hyaluronic acid dermal fillers. The last 7 years he has worked very heavily in the Regenerative Medicine space. He has represented a number of organizations marketing Stem Cell, amniotic fluid, Wharton’s jelly and exosome products.

Greg Chernoff, M.D.
Medical Director

Dr. Chernoff has performed cosmetic surgery, cosmetic treatments, and plastic surgery in Indianapolis, IN for over 30 years. Dr. Chernoff’s experience, skills, expertise, he has helped patients achieve their aesthetic facial and body rejuvenation goals in Indianapolis, IN and the surrounding cities.

Dr. Chernoff is board certified by three regulating medical authorities, including The American Board of Facial, Plastic and Reconstructive Surgery, The American Board of Otolaryngology Head and Neck Surgery, and The Royal College of Physicians and Surgeons of Canada.

Dr. Gregory Chernoff has authored numerous scientific papers and medical laser textbook chapters. He has given over 700 lectures to physicians around the world on both surgical and non-surgical therapy. He has been featured on news programs such as Dateline NBC, ABC, and CBS Nightly News, BBC World News, and in Time, Newsweek and W Magazines.

Mattioli Engineering
International Manufacturer

Mattioli Engineering developed its first Microdermabrasion System in 1991 and established the company that same year. The founders have been working in the medical industry since 1980. The company’s extensive experience in the medical and cosmetic field enables them to develop features which are protected by patented rights exclusively to Mattioli Engineering. Their presence in the USA market accounts for more than 1,500 Ultrapeel® microdermabrasion units installed and the international market with more than 4,000 units sold. Mattioli Engineering has been inspected and is compliant with the GMP rules.

Mattioli Engineering opened the American microdermabrasion market in 1996 when it introduced its Ultrapeel® Crystal and Ultrapeel® Pepita Microdermabraders. Introduction of the new proprietary Dermoelectroporation® technology  is a powered drug delivery system indicated for the local administration of ionic drug solutions into the body for medical purposes, was cleared by FDA in late 2003.

Dermoelectroporation® is the only transdermal delivery device FDA cleared as an alternative to injections.

Transdermal delivery is not a new concept to the US. For many years, technologies such as DC Current, Iontophoresis, Electroporation, and Ultrasound have been providing the benefits of transdermal delivery, however, they all had their own limitations.

So that you have a better understanding of how we developed our newest technology, Dermoelectroporation® , we thought we would provide you with the limits of the existing technologies first. Read about the science here.